1. Baskaran N, Manoharan S, Balakrishnan S, Pugalendhi P. Chemopreventive potential of ferulic acid in 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats.
Eur J Pharmacol 637:2010;22–29.
2. Saija A, Tomaino A, Trombetta D, De Pasquale A, Uccella N, Barbuzzi T, Paolino D, Bonina F.
In vitro and
in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents.
Int J Pharm 199:2000;39–47.
3. Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH, Song DK. Protection against beta-amyloid peptide toxicity
in vivo with long-term administration of ferulic acid.
Br J Pharmacol 133:2001;89–96.
4. Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.
Am J Clin Nutr 76:2002;93–99.
5. Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: therapeutic potential through its antioxidant property.
J Clin Biochem Nutr 40:2007;92–100.
6. Suzuki A, Kagawa D, Fujii A, Ochiai R, Tokimitsu I, Saito I. Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats.
Am J Hypertens 15:2002;351–357.
7. Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, Saito I. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats.
Am J Hypertens 20:2007;508–513.
8. Bayraktutan U. Free radicals, diabetes and endothelial dysfunction.
Diabetes Obes Metab 4:2002;224–238.
9. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension.
Hypertension 8:1986;II61–II66.
10. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension.
Hypertension 25:1995;1202–1211.
11. Dohi Y, Kojima M, Sato K. Endothelial modulation of contractile responses in arteries from hypertensive rats.
Hypertension 28:1996;732–737.
12. Lüscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats.
Hypertension 9:1987;157–163.
13. Callera GE, Varanda WA, Bendhack LM. Impaired relaxation to acetylcholine in 2K-1C hypertensive rat aortas involves changes in membrane hyperpolarization instead of an abnormal contribution of endothelial factors.
Gen Pharmacol 34:2000;379–389.
14. Jun JY, Yeum CH, Moon SH, Cho CH, Jun KB, Chung JH, Yoon PJ. Altered endothelial modulation of vasoconstriction in chronic two-kidney, one clip hypertensive rats. Korean J Nephrol 20:2001;381–392.
15. Sigmon DH, Beierwaltes WH. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
Hypertension 31:1998;649–656.
16. Gil-Longo J, Fernández-Grandal D, Alvarez M, Sieira M, Orallo F. Study of
in vivo and
in vitro resting vasodilator nitric oxide tone in normotensive and genetically hypertensive rats.
Eur J Pharmacol 310:1996;175–183.
17. Andriantsitohaina R, Andriambeloson E, Stoclet JC. Pharmacological approaches of endothelial nitric oxide-dependent vasorelaxation induced by polyphenols from plant extracts.
Methods Enzymol 301:1999;522–532.
18. Hiramoto K, Li X, Makimoto M, Kato T, Kikugawa K. Identification of hydroxyhydroquinone in coffee as a generator of reactive oxygen species that break DNA single strands.
Mutat Res 419:1998;43–51.
19. Bohr DF, Dominiczak AF, Webb RC. Pathophysiology of the vasculature in hypertension.
Hypertension 18(5 Suppl):1991;III69–III75.
20. Yeum CH, Oh HK, Jun JY, Jun KB, Hong SP, Yeum CH, Yoon PJ. Cardiovascular effects of nitric oxide synthesis inhibitor in renal hypertensive rats. J Korean Soc Hypertens 7:2001;35–45.
21. Pourageaud F, Freslon JL. Endothelium function in resistance and coronary arteries of spontaneously hypertensive compared to WKY rats: effects of nitro-l-arginine. Genet Hypertens 218:1992;39–41.
22. Choi S, Jun KB, Jun JY, Yoon PJ, Kim JS, Kim MY, Mun HS, Yeum CH. Effects of aminoguanidine on norepinephrine-induced vascular contraction in renovascular hypertensive rats. Korean J Nephrol 23:2004;703–713.
23. Förstermann U, Nakane M, Tracey WR, Pollock JS. Isoforms of nitric oxide synthase: functions in the cardiovascular system. Eur Heart J 14(Suppl I):1993;10–15.
24. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.
Am J Physiol 250:1986;H822–H827.
25. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
Hypertension 44:2004;248–252.
26. Park JB, Touyz RM, Chen X, Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats.
Am J Hypertens 15:2002;78–84.
27. Tanito M, Nakamura H, Kwon YW, Teratani A, Masutani H, Shioji K, Kishimoto C, Ohira A, Horie R, Yodoi J. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats.
Antioxid Redox Signal 6:2004;89–97.
28. Toda S, Kumura M, Ohnishi M. Effects of phenolcarboxylic acids on superoxide anion and lipid peroxidation induced by superoxide anion.
Planta Med 57:1991;8–10.
29. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats.
Hypertension 41:2003;341–346.